Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Share-based Compensation (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Share-based Compensation for 7 consecutive years, with $10.1 million as the latest value for Q2 2025.

  • Quarterly Share-based Compensation rose 2121.15% to $10.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $19.6 million through Jun 2025, up 2263.98% year-over-year, with the annual reading at $17.4 million for FY2025, 1999.52% up from the prior year.
  • Share-based Compensation hit $10.1 million in Q2 2025 for Benitec Biopharma, up from $6.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $10.1 million in Q2 2025 to a low of -$48000.0 in Q4 2022.
  • Historically, Share-based Compensation has averaged $1.2 million across 5 years, with a median of $237000.0 in 2021.
  • Biggest five-year swings in Share-based Compensation: crashed 120.08% in 2022 and later skyrocketed 3274.19% in 2024.
  • Year by year, Share-based Compensation stood at $239000.0 in 2021, then plummeted by 120.08% to -$48000.0 in 2022, then skyrocketed by 293.75% to $93000.0 in 2023, then surged by 3274.19% to $3.1 million in 2024, then skyrocketed by 221.35% to $10.1 million in 2025.
  • Business Quant data shows Share-based Compensation for BNTC at $10.1 million in Q2 2025, $6.0 million in Q1 2025, and $3.1 million in Q4 2024.